Shock the world: Startup snares $22M for plan to democratize defibrillation

The company's automated external defibrillator is under review by the FDA, but its leaders hope to have the device on the market by the end of the year.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.